Combination of BGJ398 with either a pan-PI3K inhibitor or a specific PIK3CA inhibitor shows synergy in FGFR2 mutant endometrial cancer cell lines. (July 2016) - Packer, L.; Geng, X.; Bonazzi, V.; Mahon, C.; Ju, R.; Stephenson, S.; Pollock, P.